Valuation: IOL Chemicals and Pharmaceuticals Limited

Market Cap 54.26B 570M 510M 471M 426M 797M 810M 5.62B 2.24B 28.4B 2.14B 2.09B 89.94B P/E 2027 *
24.6x
P/E 2028 * 17.8x
Enterprise Value 54.26B 570M 510M 471M 426M 797M 810M 5.62B 2.24B 28.4B 2.14B 2.09B 89.94B EV / Sales 2027 *
1.98x
EV / Sales 2028 * 1.67x
Free-Float
37.72%
Yield 2027 *
-
Yield 2028 * -

Last Transcript: IOL Chemicals and Pharmaceuticals Limited

1 day-3.27%
1 week+9.42%
Current month-13.71%
1 month-13.71%
3 months+23.91%
6 months+89.81%
Current year+117.39%
1 week 157.95
Extreme 157.95
189.3
1 month 157.95
Extreme 157.95
224
Current year 67.14
Extreme 67.14
224
1 year 67.14
Extreme 67.14
224
3 years 57.51
Extreme 57.51
224
5 years 54.44
Extreme 54.44
224
10 years 8.4
Extreme 8.4
224
Manager TitleAgeSince
Chief Executive Officer 34 -
Director of Finance/CFO - -
Compliance Officer - 14/11/2019
Director TitleAgeSince
Chairman 63 01/09/2007
Director/Board Member 34 29/05/2015
Chairman 73 -
Change 5-day change 1-year change 3-year change Capi.($)
-2.92%+9.42%+91.54%+111.55% 570M
+6.63%+5.13%+68.86%+145.20% 1,224B
+1.53%+2.84%+47.48%+89.01% 662B
+1.68%+1.96%+29.16%+109.31% 514B
+0.29%+2.97%+53.80%+66.80% 388B
+3.83%-0.62%+69.01%+42.32% 361B
+0.63%+4.08%+34.73%+57.41% 302B
+3.62%+5.16%+7.49%+31.98% 271B
+1.97%+3.01%+57.91%+76.14% 249B
+4.03%+5.36%+39.76%+116.14% 205B
Average +1.69%+3.11%+49.97%+84.59% 417.74B
Weighted average by Cap. +2.18%+3.04%+50.67%+96.45%

Financials

2027 *2028 *
Net sales 27.42B 288M 258M 238M 215M 403M 409M 2.84B 1.13B 14.35B 1.08B 1.06B 45.46B 32.4B 340M 305M 281M 254M 476M 483M 3.35B 1.34B 16.96B 1.28B 1.25B 53.71B
Net income 2.2B 23.08M 20.67M 19.07M 17.26M 32.27M 32.8M 228M 90.78M 1.15B 86.62M 84.78M 3.64B -
Net Debt - -
Projected Income Statement - Annual - IOL Chemicals and Pharmaceuticals Limited
Logo IOL Chemicals and Pharmaceuticals Limited
IOL Chemicals and Pharmaceuticals Limited is engaged in manufacturing and selling of pharmaceutical and chemical products. The Company operates through two segments: Chemical and Pharmaceutical. The Chemical segment produces and sells Ethyl Acetate, Iso Butyl Benzene, Acetyl Chloride, Mono Chloro Acetic Acid, Para Amino Phenol (PAP), and others. The Pharmaceutical segment produces and sells various active pharma ingredients (API) including Ibuprofen, Metformin, Fenofibrate, Lamotrigine, Clopidogrel Bisulphate, Pantoprazole, Gabapentin, Paracetamol, and others. Its API product portfolio includes Pantoprazole Sodium, Clopidogrel Bisulphate (Form II), Losartan Potassium, Levetiracetam, and Fenofibrate (Micronised). Its Specialty Chemical division includes Ethyl Acetate, Iso Butyl Benzene, Mono Chloro acetic Acid, and Acetic Anhydride. Its Ethyl Acetate is used in industries like flexible packaging, pharmaceuticals, ink, food processing, pesticides, and the paint industry.
Employees
3,095
Date Price Change Volume
30/10/26 ₹179.45 -2.92% 105,941
29/10/26 ₹184.85 +2.35% 160,897
28/10/26 ₹180.60 +0.89% 158,324
27/10/26 ₹179.00 +6.58% 113,903
26/10/26 ₹167.95 +2.78% 96,364
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
184.85INR
Average target price
223.00INR
Spread / Average Target
+20.64%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - IOL Chemicals and Pharmaceuticals Limited
  1. Stock Market
  2. Stocks
  3. IOLCP Stock